CorVel (CRVL) Competitors $101.87 +0.48 (+0.47%) As of 10:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DGX, DVA, CHE, AMED, MD, AMN, CCRN, LH, APG, and ULSShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), APi Group (APG), and UL Solutions (ULS). CorVel vs. Its Competitors Quest Diagnostics DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp APi Group UL Solutions Quest Diagnostics (NYSE:DGX) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation. Do institutionals and insiders have more ownership in DGX or CRVL? 88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 8.2% of Quest Diagnostics shares are held by company insiders. Comparatively, 47.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has preferable earnings and valuation, DGX or CRVL? Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuest Diagnostics$9.87B1.99$871M$7.9122.23CorVel$895.59M5.85$95.17M$1.8455.33 Do analysts recommend DGX or CRVL? Quest Diagnostics presently has a consensus target price of $185.73, suggesting a potential upside of 5.65%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, equities analysts plainly believe Quest Diagnostics is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DGX or CRVL more profitable? CorVel has a net margin of 10.63% compared to Quest Diagnostics' net margin of 8.81%. CorVel's return on equity of 32.55% beat Quest Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Quest Diagnostics8.81% 15.11% 6.65% CorVel 10.63%32.55%18.22% Which has more volatility & risk, DGX or CRVL? Quest Diagnostics has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, CorVel has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Does the media prefer DGX or CRVL? In the previous week, Quest Diagnostics had 13 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Quest Diagnostics and 1 mentions for CorVel. Quest Diagnostics' average media sentiment score of 1.12 beat CorVel's score of 0.55 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 11 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQuest Diagnostics beats CorVel on 10 of the 17 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.24B$5.97B$13.06B$9.00BDividend YieldN/A3.12%2.58%4.10%P/E Ratio55.4322.5328.6020.02Price / Sales5.851.9939.69120.95Price / Cash42.9713.8125.1456.90Price / Book16.245.276.225.50Net Income$95.17M$150.49M$187.50M$248.50M7 Day Performance-0.39%0.90%2.46%2.61%1 Month Performance-8.94%2.36%4.25%5.42%1 Year Performance19.54%62.97%34.53%20.76% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel1.2439 of 5 stars$101.87+0.5%N/A+17.6%$5.24B$895.59M55.465,075DGXQuest Diagnostics4.939 of 5 stars$179.74+0.2%$185.73+3.3%+29.2%$20.03B$9.87B22.7256,000Positive NewsDVADaVita4.2825 of 5 stars$136.35-0.4%$164.50+20.6%+3.1%$10.34B$12.82B13.5176,000Positive NewsCHEChemed4.9691 of 5 stars$551.14+0.5%$674.00+22.3%-13.0%$8.03B$2.43B26.8515,695Analyst ForecastAMEDAmedisys2.887 of 5 stars$97.84+0.4%$100.75+3.0%-0.8%$3.20B$2.35B36.1019,000News CoverageMDPediatrix Medical Group1.4565 of 5 stars$13.36+1.0%$16.67+24.8%+95.7%$1.14B$2.01B-13.224,305AMNAMN Healthcare Services4.2146 of 5 stars$21.15-3.5%$32.08+51.7%-55.8%$838.82M$2.98B-4.882,968News CoverageCCRNCross Country Healthcare3.8458 of 5 stars$13.30-5.2%$17.93+34.8%-4.1%$459.95M$1.34B-25.098,205LHLabcorp4.3693 of 5 stars$261.01-0.3%$274.00+5.0%+28.3%$21.92B$13.01B30.1770,000Positive NewsInsider TradeAPGAPi Group2.8227 of 5 stars$50.75-0.9%$50.57-0.3%+37.8%$14.18B$7.02B27.2529,000High Trading VolumeULSUL Solutions2.7672 of 5 stars$71.40+1.1%$69.43-2.8%+65.8%$14.16B$2.87B39.8915,094Positive News Related Companies and Tools Related Companies DGX Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives APG Alternatives ULS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
